Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Mureva Phototherapy, Inc.

Approvalsnovel device granted (FDA De Novo)26 Nov 2025

Mureva Phototherapy, Inc.

26 Nov 2025: Novel device granted (FDA De Novo) · MuReva OM™. Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
26 Nov 2025
Device
MuReva OM™
Specialty
Dental
Product Code
SGQ
Country
United States
Location
Strongsville, OH
Submitted
2024-12-23
Reference
DEN240077
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Mureva Phototherapy, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.